Liposomal Bupivacaine for Postoperative Pain After Craniotomy

NANot yet recruitingINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

December 31, 2025

Conditions
Liposome Bupivacaine
Interventions
DRUG

Liposome bupivacaine group

After standardized anesthesia induction, bilateral scalp nerve block (supprorbital nerve, auriculotemporal nerve, major occipital nerve, minor occipital nerve) was performed with liposome bupivacaine stock solution, and 1-2ml was injected into each block site.

DRUG

Ropivacaine group

After standardized anesthesia induction, bilateral scalp nerve block (supraorbital nerve, auriculotemporal nerve, major occipital nerve, minor occipital nerve) was administered with 0.5% ropivacaine, and 1-2ml was injected into each block site.

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06701539 - Liposomal Bupivacaine for Postoperative Pain After Craniotomy | Biotech Hunter | Biotech Hunter